RecruitingPhase 3Phase 4ACTRN12605000283673
Testosterone in Obese Men Trial
A 12-month Randomised, Placebo-controlled Trial of Testosterone Replacement Therapy and Lifestyle Modification Versus Lifestyle Modification Alone on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Middle-Aged and Older Men
Sponsor
PHIMR
Enrollment
40 participants
Start Date
Dec 1, 2005
Study Type
Interventional
Conditions
Eligibility
Sex: MalesMin Age: 40 YearssMax Age: 70 Yearss
Inclusion Criteria1
- BMI between 30-39.9 kg/m2 and WC equal to or greater than102cm, Serum total Testosterone <12nM.
Exclusion Criteria1
- Smokers, Significant medical condition, Sleep Apnoea, Contra-indications to Testosterone therapy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
12-month Randomised, Placebo-controlled Trial of Testosterone Replacement Therapy (Intramuscular Testosterone Undecanoate) and Lifestyle Modification.
12-month Randomised, Placebo-controlled Trial of Testosterone Replacement Therapy (Intramuscular Testosterone Undecanoate) and Lifestyle Modification.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000283673